These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20939504)

  • 1. Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.
    Rais R; Acharya C; Mackerell AD; Polli JE
    Mol Pharm; 2010 Dec; 7(6):2240-54. PubMed ID: 20939504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.
    González PM; Acharya C; Mackerell AD; Polli JE
    Pharm Res; 2009 Jul; 26(7):1665-78. PubMed ID: 19384469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.
    Balakrishnan A; Wring SA; Coop A; Polli JE
    Mol Pharm; 2006; 3(3):282-92. PubMed ID: 16749860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.
    Zheng X; Pan Y; Acharya C; Swaan PW; Polli JE
    Bioconjug Chem; 2010 Nov; 21(11):2038-48. PubMed ID: 20968316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT).
    Rais R; Fletcher S; Polli JE
    J Pharm Sci; 2011 Mar; 100(3):1184-95. PubMed ID: 20848648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.
    Balakrishnan A; Wring SA; Polli JE
    Pharm Res; 2006 Jul; 23(7):1451-9. PubMed ID: 16783481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.
    Rais R; Acharya C; Tririya G; Mackerell AD; Polli JE
    J Med Chem; 2010 Jun; 53(12):4749-60. PubMed ID: 20504026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.
    González PM; Lagos CF; Ward WC; Polli JE
    Mol Pharm; 2014 Feb; 11(2):588-98. PubMed ID: 24328955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative irreversible inhibitors of the human sodium-dependent bile acid transporter (hASBT; SLC10A2) support the role of transmembrane domain 7 in substrate binding/translocation.
    González PM; Hussainzada N; Swaan PW; Mackerell AD; Polli JE
    Pharm Res; 2012 Jul; 29(7):1821-31. PubMed ID: 22354836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).
    Balakrishnan A; Sussman DJ; Polli JE
    Pharm Res; 2005 Aug; 22(8):1269-80. PubMed ID: 16078136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2).
    Banerjee A; Ray A; Chang C; Swaan PW
    Biochemistry; 2005 Jun; 44(24):8908-17. PubMed ID: 15952798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.
    Zheng X; Ekins S; Raufman JP; Polli JE
    Mol Pharm; 2009; 6(5):1591-603. PubMed ID: 19673539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT.
    Kolhatkar V; Diao L; Acharya C; Mackerell AD; Polli JE
    J Pharm Sci; 2012 Jan; 101(1):116-26. PubMed ID: 22109685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
    Balakrishnan A; Polli JE
    Mol Pharm; 2006; 3(3):223-30. PubMed ID: 16749855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased acyclovir oral bioavailability via a bile acid conjugate.
    Tolle-Sander S; Lentz KA; Maeda DY; Coop A; Polli JE
    Mol Pharm; 2004 Jan; 1(1):40-8. PubMed ID: 15832499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol modulates human intestinal sodium-dependent bile acid transporter.
    Alrefai WA; Sarwar Z; Tyagi S; Saksena S; Dudeja PK; Gill RK
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G978-85. PubMed ID: 15604201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine Phosphorylation Regulates Plasma Membrane Expression and Stability of the Human Bile Acid Transporter ASBT (
    Chothe PP; Czuba LC; Ayewoh EN; Swaan PW
    Mol Pharm; 2019 Aug; 16(8):3569-3576. PubMed ID: 31194565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of novel synthetic MTS conjugates of bile acids for site-directed sulfhydryl labeling of cysteine residues in bile acid binding and transporting proteins.
    Ray A; Banerjee A; Chang C; Khantwal CM; Swaan PW
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1473-6. PubMed ID: 16387497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the intestinal bile acid transporters in bile acid and drug disposition.
    Dawson PA
    Handb Exp Pharmacol; 2011; (201):169-203. PubMed ID: 21103970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.
    Moore RH; Chothe P; Swaan PW
    Biochemistry; 2013 Jul; 52(30):5117-24. PubMed ID: 23815591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.